Preterm labor: current pharmacotherapy options for tocolysis

Area of Science:

• Obstetric Care
• Neonatal Medicine
• Pharmacology

Background:

• Preterm birth is a significant issue in developed countries, with adverse neonatal outcomes linked to gestational age.
• Current treatments for preterm labor focus on inhibiting contractions to allow for transfer and corticosteroid administration.
• Pathophysiological mechanisms of preterm birth are not fully understood, hindering preventive strategy development.

Purpose of the Study:

• To review current pharmacological therapies for managing preterm labor.
• To evaluate the effectiveness and safety profiles of different tocolytic agents.

Main Methods:

• Systematic review of existing literature on pharmacological interventions for preterm labor.
• Analysis of clinical trial data and expert opinions on tocolytic efficacy and safety.

Main Results:

• Atosiban and nifedipine are recommended for initial tocolysis, showing the best effectiveness and side effect profiles for short-term use (48 hours).
• Progesterone has a limited role in acute tocolysis but may be useful in preterm labor prevention or as an adjunct therapy.

Conclusions:

• While atosiban and nifedipine are favored for initial tocolysis, robust data on their beneficial impact on neonatal outcomes are lacking.
• The overall effectiveness of tocolytics in improving neonatal outcomes requires further investigation.
• Progesterone's role in preterm labor management, particularly in prevention, warrants further study.